Status:
COMPLETED
INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
Lead Sponsor:
Vivencio Barrios
Collaborating Sponsors:
Bayer
Conditions:
Atrial Fibrillation and Flutter
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study was to determine rates of INR control of patients with nonvalvular AF daily attended in primary care in Spain. PAULA is an observational retrospective/cross-sectio...
Detailed Description
Vitamin K antagonists (VKAs) have traditionally been used for long-term prevention of thromboembolic complications in patients with atrial fibrillation (AF). Because of the variability in the dose res...
Eligibility Criteria
Inclusion
- Patients aged ≥18 years old with
- nonvalvular AF,
- treated with VKAs for at least one year in primary care
- At least 80% of INR values during the past 12 months should be available.
- Written consent should be provided before inclusion.
Exclusion
- Patients that do not sign or understand written consent.
- Participating in a clinical trial in the last 12 months.
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
1524 Patients enrolled
Trial Details
Trial ID
NCT02273609
Start Date
February 1 2014
End Date
October 1 2014
Last Update
October 29 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.